Skip to search formSkip to main contentSkip to account menu

Myobloc

Known as: Elan brand of botulinum toxin type B, NeuroBloc 
National Institutes of Health

Related topics

Related topics

4 relations
2 ML rimabotulinumtoxinB 5000 UNT/ML Injection [Myobloc]

Broader (3)

Botulinum Toxinsbotulinum toxin type BrimabotulinumtoxinB

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2015
2015
Repeated treatments of drooling with botulinum toxin B in neurology
To investigate efficacy, saliva flow, and composition in repeated BoNT‐B treatments of drooling. 
2013
2013
Botulinum toxin field assays evaluated using cosmetic botox preparations.
Several quick tests for identifying botulinum toxins (BoNTs) are commercially available, but generally these tests have not been… 
2012
2012
Pharmakologie der Botulinumtoxinmedikamente
ZusammenfassungBotulinumtoxin (BT) wird mit großem Erfolg angewendet zur Behandlung verschiedenster Erkrankungen, die durch… 
2009
2009
Xeomin® in the treatment of cervical dystonia
Background and purpose:  Botulinum toxin type A (BoNT/A) is a highly effective and well‐tolerated treatment for focal dystonias… 
2006
2006
Pharmakologische Aspekte therapeutischer Botulinum-Toxin-Präparationen
ZusammenfassungTherapeutische Präparationen von Botulinum-Toxin (BT) bestehen aus Botulinum-Neurotoxin (BNT), Komplexproteinen… 
2005
2005
Botulinum toxin A (Botox®) and sweating-dose efficacy and comparison to other BoNT preparations
2005
2005
The use of botulinum toxin type‐B in the treatment of patients who have become unresponsive to botulinum toxin type‐A – initial experiences
The increasing use of botulinum toxin type‐A, especially for focal dystonia and spasticity has highlighted the issue of secondary… 
2005
2005
Botulinum toxin type B de novo therapy of cervical dystonia
AbstractBotulinum toxin induced therapy failure type B antibody (BT–B, BT–B–AB) has so far only been reported after previous… 
2002
2002
Erste Erfahrungen mit der klinischen Anwendung von Botulinum-Toxin Typ B
ZusammenfassungSeit kurzem steht Botulinum-Toxin Typ B (BT-B) zur Behandlung der zervikalen Dystonie (ZD) zur Verfügung. In der… 
2002
2002
Behandlung der Adduktorenspastik mit Botulinumtoxin Typ B
ZusammenfassungZur Behandlung von fokalen spastischen Muskeltonuserhöhungen liegen derzeit nur Studien mit Botulinumtoxin Typ A… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)